We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Thermo Electron Acquires Instrument Validation Firm

By HospiMedica staff writers
Posted on 14 Nov 2003
In a transaction that will enable the company to offer instrument validation and other services to its customers, Thermo Electron Corp. (Waltham, MA, USA) has acquired Laboratory Management Systems Inc. (LMSi, New Castle, DE, USA). Terms were not disclosed.

LMSi specializes in performing instrument and computer systems validation, metrology, and certification. The company has developed a broad portfolio of analytical instrument validation protocols and operating procedures that enable laboratories to comply with US Food and Drug Administration requirements. LMSi had revenues of US$11 million in 2003.

"This acquisition is an important step in our strategy to offer customers comprehensive laboratory solutions that include full product support, for almost any instrument, anywhere,” said Marijn E. Dekkers, president and CEO of Thermo Electron. "Adding LMSi's regulatory and compliance expertise to our global laboratory service network will allow us to be a regulatory validation and consulting partner to customers who face increasing productivity, quality, and regulatory challenges.”




Related Links:
Thermo Electron
LMSi

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Nuclear Matrix Protein 22 Test
NMP22 Test
New
Lab Sample Rotator
H5600 Revolver

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests